Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Wednesday that its second quarter revenues fell 25 percent year over year, with a decline in revenues for genomics and infectious disease testing products offsetting increased revenues in specimen collection devices.

For the three months ended June 30, the Bethlehem, Pennsylvania-based company reported revenues of $29.3 million, down from $38.8 million a year earlier and missing the analysts' average estimate of $32.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.